Clinical Trials in Salt Lake City

Showing 9261-9280 of 16,694 trials

Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants

NCT03640494

The purpose of this study is to develop a novel noninvasive bedside optical coherence tomography (OCT) imaging technique in newborn infants with HIE that improves our ability to assess the range of retinal effects from HIE and to diagnose and monitor treatments of HIE.

Hypoxic-Ischemic Encephalopathy

Duke University57 participantsStarted Aug 2018

Durham, North Carolina, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 1< 1 mile

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

NCT02501902

This is a Phase 1, open label, multi center, multiple dose, dose escalation, safety, pharmacokinetic and pharmacodynamic study of palbociclib in combination with nab-P, in sequential cohorts of adult patients with mPDAC, with MTD expansion cohort(s). Approximately 30-60 patients are expected to be enrolled in the overall study.

Metastatic Pancreatic Ductal Adenocarcinoma

Pfizer76 participantsStarted Nov 2015

Scottsdale, Arizona, United States • Scottsdale, Arizona, United States • La Jolla, California, United States +23 more locations

Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Find Trials by Condition in Salt Lake City

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Acute Effect of Systemic Stress on Measured Blood Concentrations of 25 (OH) Vitamin D

Recovery of Hibernating Myocardium in End Stage Heart Failure

PLUG Dementia Trial and MRI PLUG Dementia Sub-Study

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Essure (Model ESS310) Placement Rate Study

ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Rheos System for the Treatment of HFpEF Heart Failure

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

Wide Frequency Band Test of Hearing in Veterans

Ultra-Low Tidal Volume Mechanical Ventilation in ARDS Through ECMO